{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:00:22Z","timestamp":1793678422623,"version":"4.5.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.coi.2025.102715","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:51:58Z","timestamp":1768006318000},"page":"102715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Metabolomic signaling in sarcoidosis pathogenesis"],"prefix":"10.1016","volume":"99","author":[{"given":"Humphrey","family":"Lotana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonder Puryear","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102715_bib1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2025.102715_bib2","doi-asserted-by":"crossref","first-page":"C1336","DOI":"10.1152\/ajpcell.00316.2023","article-title":"The role of the host-microbiome and metabolomics in sarcoidosis","volume":"325","author":"Kim","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"issue":"Supplement_6","key":"10.1016\/j.coi.2025.102715_bib3","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1513\/AnnalsATS.201707-566OT","article-title":"High-risk sarcoidosis. current concepts and research imperatives","volume":"14","author":"Sauer","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.coi.2025.102715_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01340","article-title":"Environmental risk factors for sarcoidosis","volume":"11","author":"Judson","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102715_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/jomfp.jomfp_373_21","article-title":"Sarcoidosis \u2014\u00a0a\u00a0review article","volume":"26","author":"Sreeja","year":"2022","journal-title":"J Oral Maxillofac Pathol"},{"key":"10.1016\/j.coi.2025.102715_bib6","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3390\/jcm9041081","article-title":"Sarcoidosis: causes, diagnosis, clinical features, and treatments","volume":"9","author":"Jain","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.coi.2025.102715_bib7","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210785","article-title":"CD4+ T cells in the lungs of acute sarcoidosis patients recognize an Aspergillus nidulans epitope","volume":"218","author":"Greaves","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2025.102715_bib8","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s10875-012-9700-5","article-title":"Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL","volume":"32","author":"Oswald-Richter","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2025.102715_bib9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0140-6736(98)12310-3","article-title":"Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis","volume":"354","author":"Ishige","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2025.102715_sbref10","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175264","article-title":"Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis","volume":"134","author":"Weeratunga","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102715_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00437","article-title":"Granuloma formation in pulmonary sarcoidosis","volume":"4","author":"Broos","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102715_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/diagnostics14040395","article-title":"High-risk sarcoidosis: a focus on pulmonary, cardiac, hepatic and renal advanced diseases, as well as on calcium metabolism abnormalities","volume":"14","author":"Isra\u00ebl-Biet","year":"2024","journal-title":"Diagnostics"},{"issue":"Supplement_6","key":"10.1016\/j.coi.2025.102715_bib13","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1513\/AnnalsATS.201707-567OT","article-title":"Application of \"omics\" and systems biology to sarcoidosis research","volume":"14","author":"Crouser","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.coi.2025.102715_bib14","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102715_bib15","article-title":"The role of diverse immune cells in sarcoidosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102715_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/thx.2010.140319","article-title":"Sarcoidosis is a Th1\/Th17 multisystem disorder","volume":"66","author":"Facco","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.coi.2025.102715_bib17","doi-asserted-by":"crossref","first-page":"21463","DOI":"10.3390\/ijms141121463","article-title":"Imbalance between Th17 and regulatory T-Cells in sarcoidosis","volume":"14","author":"Huang","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2025.102715_bib18","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1164\/rccm.201512-2419ED","article-title":"Sarcoidosis and T-helper cells. Th1, Th17, or Th17.1?","volume":"193","author":"Georas","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2025.102715_bib19","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-\u03b3-producing T-helper 17.1 cells are increased in sarcoidosis and are more prevalent than T-helper type 1 cells","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2025.102715_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01124-2017","article-title":"Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes","volume":"51","author":"Broos","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coi.2025.102715_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/metabo10050181","article-title":"Metabolome-microbiome crosstalk and human disease","volume":"10","author":"Lee-Sarwar","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.coi.2025.102715_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-022-00548-6","article-title":"Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia","volume":"17","author":"Connell","year":"2022","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.coi.2025.102715_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114295","article-title":"Metabolite interactions between host and microbiota during health and disease: which feeds the other?","volume":"160","author":"Zhang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.coi.2025.102715_bib24","doi-asserted-by":"crossref","first-page":"8553","DOI":"10.1074\/jbc.R116.752899","article-title":"Microbial metabolites in health and disease: navigating the unknown in search of function","volume":"292","author":"Martinez","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2025.102715_bib25","doi-asserted-by":"crossref","first-page":"8560","DOI":"10.1074\/jbc.R116.765388","article-title":"Targeting of microbe-derived metabolites to improve human health: the next frontier for drug discovery","volume":"292","author":"Brown","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2025.102715_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12858","article-title":"Immunometabolism: from basic mechanisms to translation","volume":"295","author":"Makowski","year":"2020","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2025.102715_bib27","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2025.102715_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.coi.2025.102715_bib29","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","article-title":"Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation","volume":"115","author":"Krawczyk","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102715_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11306-015-0932-2","article-title":"Metabolomics connects aberrant bioenergetic, transmethylation, and gut microbiota in sarcoidosis","volume":"12","author":"Geamanu","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.coi.2025.102715_bib31","first-page":"29","article-title":"Plasma metabolomic profile in fibrosing pulmonary sarcoidosis","volume":"33","author":"Mirsaeidi","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse\u00a0Lung Dis"},{"key":"10.1016\/j.coi.2025.102715_bib32","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/pros.23222","article-title":"Accumulation of palmitoylcarnitine and its effect on pro-inflammatory pathways and calcium influx in prostate cancer","volume":"76","author":"Al-Bakheit","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.coi.2025.102715_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1012827","article-title":"Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2","volume":"9","author":"Casanova","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.coi.2025.102715_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2249.1997.d01-905.x","article-title":"Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: correlation with the clinical parameters","volume":"107","author":"Takizawa","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2025.102715_bib35","first-page":"10","article-title":"Nuclear magnetic resonance spectroscopic analysis of salivary metabolome in sarcoidosis","volume":"33","author":"Duchemann","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.coi.2025.102715_bib36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/life14050559","article-title":"Short-chain fatty acids and human health: from metabolic pathways to current therapeutic implications","volume":"14","author":"Facchin","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.coi.2025.102715_bib37","article-title":"Quantification of short chain fatty acids (acetate, butyrate, propionate) in human blood with ion exclusion chromatography","volume":"26","author":"Bertges","year":"2021","journal-title":"Pract Lab Med"},{"key":"10.1016\/j.coi.2025.102715_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01219-9","article-title":"Short-chain fatty acids in diseases","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.coi.2025.102715_bib39","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1080\/09637486.2022.2078285","article-title":"Short-chain fatty acids, acetate and propionate, directly upregulate osteoblastic differentiation","volume":"73","author":"Kondo","year":"2022","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.coi.2025.102715_sbref40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s42255-024-01191-9","article-title":"Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression","volume":"7","author":"Nshanian","year":"2025","journal-title":"Nat Metab"},{"key":"10.1016\/j.coi.2025.102715_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56174-8","article-title":"Metabolomic and metallomic profile differences between veterans and civilians with pulmonary sarcoidosis","volume":"9","author":"Banoei","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2025.102715_sbref42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/metabo15010007","article-title":"Investigating metabolic phenotypes for sarcoidosis diagnosis and exploring immunometabolic profiles to unravel disease mechanisms","volume":"15","author":"Banoei","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.coi.2025.102715_bib43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/tcmj.tcmj_83_21","article-title":"The potential of using itaconate as treatment for inflammation-related heart diseases","volume":"34","author":"Ku","year":"2022","journal-title":"Tzu Chi Med J"},{"key":"10.1016\/j.coi.2025.102715_bib44","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1600-0625.2010.01107.x","article-title":"Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARgamma activation","volume":"19","author":"Mastrofrancesco","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.coi.2025.102715_sbref45","doi-asserted-by":"crossref","first-page":"00763","DOI":"10.1183\/23120541.00763-2024","article-title":"1H NMR urine metabolomic fingerprint for severity discrimination in pulmonary sarcoidosis","volume":"11","author":"Jeny","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.coi.2025.102715_sbref46","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202503-0772RL","article-title":"Sarcoidosis resolvers and progressors demonstrate distinct systemic metabolomic profiles","volume":"211","author":"Ma","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2025.102715_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-025-03863-y","article-title":"Serum metabolomics in pulmonary sarcoidosis: metabolic signatures across prognoses","volume":"25","author":"Zhu","year":"2025","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.coi.2025.102715_bib48","doi-asserted-by":"crossref","DOI":"10.1007\/s11306-023-02052-4","article-title":"Clinical metabolomics by NMR revealed serum metabolic signatures for differentiating sarcoidosis from tuberculosis","volume":"19","author":"Rai","year":"2023","journal-title":"Metabolomics"},{"key":"10.1016\/j.coi.2025.102715_bib49","article-title":"Identification of serum biomarkers for active pulmonary tuberculosis using a targeted metabolomics approach","volume":"10","author":"Cho","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2025.102715_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1099654","article-title":"Biomarker discovery for tuberculosis using metabolomics","volume":"10","author":"Yu","year":"2023","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.coi.2025.102715_sbref51","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00186-25","article-title":"Revealing pathogenesis-associated metabolites in Histoplasma capsulatum through comprehensive metabolic profiling","volume":"10","author":"Heckart","year":"2025","journal-title":"mSystems"},{"key":"10.1016\/j.coi.2025.102715_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02972-21","article-title":"A Histoplasma capsulatum lipid metabolic map identifies antifungal targets","volume":"12","author":"Zamith-Miranda","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.coi.2025.102715_bib53","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1021\/acs.jproteome.9b00100","article-title":"Coccidioidomycosis detection using targeted plasma and urine metabolic profiling","volume":"18","author":"Jasbi","year":"2019","journal-title":"J Proteome Res"},{"key":"10.1016\/j.coi.2025.102715_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00258-20","article-title":"Metabolomics and machine learning approaches combined in pursuit for more accurate paracoccidioidomycosis diagnoses","volume":"5","author":"Lima","year":"2020","journal-title":"mSystems"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:32:27Z","timestamp":1784539947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791525001918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":54,"alternative-id":["S0952791525001918"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102715","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic signaling in sarcoidosis pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102715"}}